Patent · US Active

Anti-IL-23 antibodies

US11078265B2 · kind B2 · utility

1Cited by

38References

32Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Gerald Henry NABOZNY · New Milford, US
Annette Bettina GALLER · Undenheim, DE
Patrick Garidel · Norderstedt, DE
William Troy LOGING · Newtown, US
Steven John PADULA · Simsbury, US
Torsten Schultz-Fademrecht · Maselheim, DE
Elaine Ee-Ling WANG · Toronto, CA

Key dates

Filing date	Apr 25, 2013
Grant date	Aug 3, 2021
Priority date	—
Expiry date	Feb 4, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies, pharmaceutical compositions and therapeutic and diagnostic methods and compositions for using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.